Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Loratadine/Montelukast vs Pseudoephedrine in Seasonal Allergic Rhinitis
NCT00319995Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Mar 2006
- Primary completion
- Jun 2006
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of loratadine, montelukast in seasonal allergic rhinitis (SAR), sponsored by Organon & Co.. Started Mar 2006; status: completed.
02
Drugs
loratadinemontelukast
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT00319995.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00319995.